TORONTO, ONTARIO--(Marketwired - Oct. 8, 2015) - BlueOcean NutraSciences Inc. (TSX VENTURE:BOC) announces that the Board of Directors has approved as of October 7, 2015, the grant of an aggregate of 60,000 stock options (the "Options") to a member of the Board of Directors. The Options have a term of 5 years and are exercisable into common shares of the Company at an exercise price of $0.085, all in accordance with the Company's stock option plan.
About BlueOcean NutraSciences
BlueOcean is a Canadian company that develops specialty oils using innovative product platforms targeted at the rapidly growing health and Wellness and Animal Feed markets.
BlueOcean is developing specialty oil products from multiple sources. BlueOcean owns 50% of the participating and voting rights in 70717 Newfoundland and Labrador Ltd, a joint venture with a major Atlantic Canada shrimp processor that provides the shrimp feedstock for the extraction of AstaShrimp, and 50% of Asta NutraSciences Inc. BlueOcean wholly owns its AlgaOmega product line.
Forward-Looking Statements
This news release may contain forward-looking statements that are based on BlueOcean's expectations, estimates and projections regarding its business and the economic environment in which it operates. These statements are not guarantees of future performance and involve risks and uncertainties that are difficult to control or predict. Therefore, actual outcomes and results may differ materially from those expressed in these forward-looking statements and readers should not place undue reliance on such statements. Statements speak only as of the date on which they are made, and the Company undertakes no obligation to update them publicly to reflect new information or the occurrence of future events or circumstances, unless otherwise required to do so by law.
Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.